Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2025-06-17 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing an administrative warning letter received from SEBI regarding a violation of insider trading regulations by a designated person of the company. It is a regulatory disclosure under SEBI Listing Regulations, specifically Regulation 30, which mandates timely disclosure of material events. The document does not contain financial statements, audit information, or detailed reports but is a compliance announcement about a regulatory action. The document length is short (2195 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-06-17 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to BSE Limited and NSE India regarding a newspaper advertisement about the intimation of the 41st Annual General Meeting (AGM) of Neuland Laboratories Limited. It references Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of advertisements related to AGMs. The content includes details about the AGM date, record date, and related information published in newspapers. There is no substantive financial data, management discussion, or detailed report content. The document is essentially an announcement of the AGM and related information, not the AGM materials themselves or the full annual report. The document length is 15,000 characters, but the content is primarily a notification and advertisement copy. Therefore, the appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM.
2025-06-17 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of a Letter of Confirmation in lieu of lost/misplaced share certificates. It references SEBI regulations related to share certificate handling and provides details of the shareholder and shares involved. The content is an official notification about share certificate replacement, not a financial report, earnings release, or management discussion. It does not contain financial data or analysis, nor does it announce voting results or capital changes. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2025-06-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 90% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about notifying the schedule of investor meetings (a non-deal roadshow) and does not contain any financial data, report, or results. It is an update related to investor relations activities rather than a financial report or announcement of voting results, management changes, or capital changes. Therefore, the document fits best under the category of Capital/Financing Update (CAP) as it relates to investor meetings and engagement activities, which are part of capital market communications.
2025-06-11 English
Updates
Regulatory Filings
2025-06-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about notifying the market and regulators of planned investor interactions, not a financial report, earnings release, or any detailed presentation. It does not contain financial data or results, nor is it a report publication announcement. This type of document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories.
2025-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.